[Prostatic markers, today and tomorrow].
Terrone
C
C
Faraone
N
N
Aimo
G
G
Priolo
G
G
D000954:Antigens, Surface; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002268:Carboxypeptidases / Q000032:analysis / Q000378:metabolism; D003937:Diagnosis, Differential; D043425:Glutamate Carboxypeptidase II; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009928:Organ Specificity; D011467:Prostate / Q000378:metabolism*; D017430:Prostate-Specific Antigen / Q000032:analysis / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020840:Tissue Kallikreins / Q000378:metabolism
D000954:Antigens, Surface; D014408:Biomarkers, Tumor; D012333:RNA, Messenger; D002268:Carboxypeptidases; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II; D020840:Tissue Kallikreins; D017430:Prostate-Specific Antigen